Reshaping Intratumoral Mononuclear Phagocytes with Antibody-Opsonized Immunometabolic Nanoparticles
Advanced science (Weinheim, Baden-Wurttemberg, Germany)(2023)
摘要
Mononuclear phagocytes (MPs) are vital components of host immune defenses against cancer. However, tumor-infiltrating MPs often present tolerogenic and pro-tumorigenic phenotypes via metabolic switching triggered by excessive lipid accumulation in solid tumors. Inspired by viral infection-mediated MP modulation, here enveloped immunometabolic nanoparticles (immeNPs) are designed to co-deliver a viral RNA analog and a fatty acid oxidation regulator for synergistic reshaping of intratumoral MPs. These immeNPs are camouflaged with cancer cell membranes for tumor homing and opsonized with anti-CD163 antibodies for specific MP recognition and uptake. It is found that internalized immeNPs coordinate lipid metabolic reprogramming with innate immune stimulation, inducing M2-to-M1 macrophage repolarization and tolerogenic-to-immunogenic dendritic cell differentiation for cytotoxic T cell infiltration. The authors further demonstrate that the use of immeNPs confers susceptibility to anti-PD-1 therapy in immune checkpoint blockade-resistant breast and ovarian tumors, and thereby provide a promising strategy to expand the potential of conventional immunotherapy. Antibody-opsonized immunometabolic nanoparticles target intratumoral mononuclear phagocytes (MPs) for binary lipid metabolic reprogramming and innate immune stimulation, reverse their immunosuppressive phenotypes to reboot immune surveillance in lipid-enriched tumor microenvironment, and overcome immunotherapy resistance in breast and ovarian cancers.image
更多查看译文
关键词
biomimetic nanoparticle,immunometabolic reshaping,innate immune stimulation,lipid metabolic reprogramming,mononuclear phagocyte
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要